Heilongjiang Jiren Pharmaceutical

Heilongjiang Jiren Pharmaceutical is a specialized pharmaceutical company based in Harbin, China, that focuses on the development and manufacturing of Traditional Chinese Medicine (TCM) and modern drug formulations. The company's product portfolio is primarily centered on urology, respiratory diseases, and pediatric care, featuring well-known brands like the Qianliexin Capsule for chronic prostatitis. Jiren Pharmaceutical operates advanced production lines for various dosage forms, including capsules, tablets, and granules, all adhering to national GMP standards. As a recognized high-tech enterprise, it leverages regional resources in Northeast China to maintain a competitive edge in the domestic TCM market. The company has historically been listed on China's New Third Board (NEEQ), reflecting its established position in the regional healthcare sector.